Literature DB >> 25870333

The high risk of an HIV diagnosis following a diagnosis of syphilis: a population-level analysis of New York City men.

Preeti Pathela1, Sarah L Braunstein2, Susan Blank3, Colin Shepard2, Julia A Schillinger3.   

Abstract

BACKGROUND: Epidemiologic studies have shown that syphilis is associated with risk for human immunodeficiency virus (HIV) infection. We used population-level syphilis and HIV data to quantify HIV incidence among men following primary or secondary (P&S) syphilis diagnoses and identify the highest-risk subgroups for intensified prevention, such as pre-exposure prophylaxis with antiretroviral medications.
METHODS: Male cases reported to the New York City HIV/AIDS and Sexually Transmitted Disease (STD) surveillance registries were matched using a deterministic algorithm. We measured HIV incidence following P&S syphilis diagnosed between 2000 and June 2010 and identified risk factors for HIV infection using Cox proportional hazards models.
RESULTS: Of 2805 men with syphilis contributing 11 714 person-years of follow-up, 423 (15.1%) acquired HIV; annual incidence was 3.61% (95% confidence interval [CI], 3.27%, 3.97%). HIV incidence was high among: men who have sex with men (MSM) (5.56%, 95% CI, 5.02%-6.13%); males with secondary compared with primary syphilis (4.10% vs 2.64%, P < .0001); and males diagnosed with another bacterial STD after syphilis (7.89%, 95% CI, 6.62%-9.24%).
CONCLUSIONS: HIV incidence among men diagnosed with syphilis is high; one in 20 MSM were diagnosed with HIV within a year. Our data have implications for syphilis and HIV screening and may be useful for further targeting HIV-negative populations for pre-exposure prophylaxis.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV incidence; syphilis

Mesh:

Year:  2015        PMID: 25870333     DOI: 10.1093/cid/civ289

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  42 in total

Review 1.  Infection in 2015: HIV protection with PrEP - implications for controlling other STIs.

Authors:  Douglas S Krakower; Kenneth H Mayer
Journal:  Nat Rev Urol       Date:  2015-12-01       Impact factor: 14.432

2.  Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report.

Authors:  Stephanie E Cohen; Darpun Sachdev; Sulggi A Lee; Susan Scheer; Oliver Bacon; Miao-Jung Chen; Hideaki Okochi; Peter L Anderson; Mary F Kearney; Susa Coffey; Hyman Scott; Robert M Grant; Diane Havlir; Monica Gandhi
Journal:  Lancet HIV       Date:  2018-11-29       Impact factor: 12.767

3.  Why we need pre-exposure prophylaxis: incident HIV and syphilis among men, and transgender women, who have sex with men, Bangkok, Thailand, 2005-2015.

Authors:  T H Holtz; W Wimonsate; P A Mock; S Pattanasin; W Chonwattana; W Thienkrua; W Sukwicha; M E Curlin; A Chitwarakorn; E F Dunne
Journal:  Int J STD AIDS       Date:  2019-01-09       Impact factor: 1.359

4.  Rigour after gonorrhea treatment in a 55-year-old man.

Authors:  Patrick O'Byrne
Journal:  Can Fam Physician       Date:  2019-02       Impact factor: 3.275

5.  Novel Approaches for Development of Human Immunodeficiency Virus Preexposure Prophylaxis Agents.

Authors:  Myron S Cohen; Deborah Donnell
Journal:  J Infect Dis       Date:  2020-01-02       Impact factor: 5.226

6.  Assessing the Role of Long-Acting Cabotegravir Preexposure Prophylaxis of Human Immunodeficiency Virus: Opportunities and Aspirations.

Authors:  Myron S Cohen; Raphael J Landovitz
Journal:  J Infect Dis       Date:  2021-01-04       Impact factor: 5.226

7.  Syphilis Control in the Post-Elimination Era: Implications of a New Syphilis Control Initiative for STD/HIV Programs.

Authors:  Matthew R Golden; Julia C Dombrowski
Journal:  Sex Transm Dis       Date:  2017-12-14       Impact factor: 2.830

8.  Another step forward in using surveillance for prevention.

Authors:  Matthew Hogben; Kaytlin J Renfro
Journal:  Lancet HIV       Date:  2020-07       Impact factor: 12.767

9.  STD Partner Services to Monitor and Promote HIV Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men.

Authors:  David A Katz; Julia C Dombrowski; Michael Barry; Dawn Spellman; Teal R Bell; Matthew R Golden
Journal:  J Acquir Immune Defic Syndr       Date:  2019-04-15       Impact factor: 3.731

Review 10.  Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies.

Authors:  Sarah E Rutstein; Dawn K Smith; Shona Dalal; Rachel C Baggaley; Myron S Cohen
Journal:  Lancet HIV       Date:  2020-08-27       Impact factor: 12.767

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.